InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: None

Friday, 10/09/2020 12:09:06 PM

Friday, October 09, 2020 12:09:06 PM

Post# of 233305
Next Week's Deadline

If Nader does not have his results as promised, the share price will plunge and rightly so. Having the results but not tabulated will be equally unacceptable and Nader will have failed to keep another promise.

At which point Nader being allowed to remain CEO is an indefensible position.

Now The Good News

If we have significant results regarding mortality it is a major win. The study may be stopped and an EUA forthcoming because the end point is mortality. That's the study right there and the primary endpoint achieved.

If interim shows progress and is not stopped but there isn't enough for an EUA, at the end of the trial we will more than likely have what we need for an approval.

Now The Bad News

Whether we are EUA worthy or approval worthy we come back to having to rely on Nader to have all his I's dotted and T's crossed. And he has proven morbidly incapable of doing that. I do mean morbidly because if you think about it all the delays are on him, and those delays have cost lives.

If he had not gone EIND crazy, had he executed his duties competently, this drug would be out on the market and someone would not be grieving the preventable death of a loved one.

I want to emphasis that point. There have been preventable deaths occurring because Nader failed to do his job.

So the next time you want to cheer him on remember that. Nader is responsible for the loss of life because he couldn't do his job.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News